In markets such as the medical industry, GMS’ aptitude for producing field capable rugged computer systems that are compact, powerful, and reliable have introduced many new opportunities in precision applications. GMS has identified new computing intensive and response time critical applications in the medical device market which are befitting for high performance medical technologies, such as imaging and diagnostics (MRI, CT, etc.) and precision radiation cancer therapy delivery systems (such as IMRT). GMS also understands that the less demanding medical applications require comprehensive computing technology, thus we have also been dedicated to developing low cost board level products for those applications.
Major medical companies, such as BD Biosciences, have utilized General Micro Systems’ medical electronics for applications such as blood analyzers, patient diagnosis and other computer intensive analysis that requires accuracy, guaranteed security, and cost effectiveness. Our rugged smart displays are also a popular product among medical industry authorities, both in and out of the field, because of their resistance to common elements that harm normal displays, such as certain chemicals and gases.
One reason why the medical industry’s original equipment manufacturers (OEMs) rely on GMS is because we understand the importance of the longevity, configuration management and the stability of a supply chain throughout a product’s lifecycle. Medical technology is expensive, which is why we offer one of the most competitive and extensive useful lifecycle lengths and lowest cost of ownership in the industry at a great value. During inevitable tech refresh cycles our systems are designed for a truly seamless migration from one generation of a product to the next, ensuring an easy product continuation/configuration transition.
General Micro Systems will continue to serve the medical community by anticipating customers’ future needs and delivering products ahead of the curve rather than responding to customer requests and trailing the market. This process results in a strong research and development pipeline and constant and consistent market innovation.